Therefore, rather than broad MEK‐ERK1/2 pathway inhibition or EphA2 knockdown, the specific RSK‐EphA2‐pS897 blockade and consequent reversal to tumor‐suppressive EphA2‐pY588 correlated with the effective OC cell elimination and sensitization to platinum. Here, MAPK3 is linked to neoplasm.